Knut E. A. Lundin

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

Øyvind Molberg, Stephen N. McAdam, Roman Körner et al. · Nature Medicine · 1998 · 1.2K citations

Inflammation, Autoimmune Disease, Mucosal Immunology +11

Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology

Jonas F. Ludvigsson, Julio C. Bai, Federico Biagi et al. · Gut · 2014 · 1.1K citations · Full text

British Society, Hepatology, Adult Coeliac Disease +12

European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders

Abdulbaqi Al–Toma, Umberto Volta, Renata Auricchio et al. · United European Gastroenterology Journal · 2019 · 939 citations · Full text

Food Intolerance, Autoimmune Disease, Coeliac Disease +10

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 789 citations

Oncology, Clinical Translation, Originator Infliximab +10

The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase

Helene Arentz–Hansen, Roman Körner, Øyvind Molberg et al. · The Journal of Experimental Medicine · 2000 · 654 citations · Full text